Data / Form D filings / Terrestrial Bio, Inc.
Terrestrial Bio, Inc.: Form D filings
Terrestrial Bio, Inc., a biotechnology company in Woburn, MA, filed 12 Form D notices with the SEC between 2013 and 2026. The latest, on March 19, 2026, reports $57.3 million sold of a $83.5 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 30 CUMMINGS PARK DRIVE, Woburn, MA, 01801
- Phone
- (614) 507-9586
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1578117
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | New notice | $83,538,199 | $57,301,758 | $26,236,441 | 16 | Mar 4, 2026 | sec.gov |
| Sep 10, 2025 | New notice | $10,000,000 | $7,903,411 | $2,096,589 | 4 | Aug 27, 2025 | sec.gov |
| Feb 26, 2025 | New notice | $10,000,000 | $8,400,000 | $1,600,000 | 3 | Feb 14, 2025 | sec.gov |
| May 28, 2024 | New notice | $12,000,000 | $10,775,983 | $1,224,017 | 6 | May 13, 2024 | sec.gov |
| Jul 24, 2023 | New notice | $12,096,986 | $9,096,986 | $3,000,000 | 4 | Jul 17, 2023 | sec.gov |
| Dec 23, 2022 | Amendment | $35,012,500 | $35,012,500 | 7 | Apr 29, 2021 | sec.gov | |
| Oct 4, 2022 | New notice | $2,000,000 | $2,000,000 | 1 | Sep 22, 2022 | sec.gov | |
| May 14, 2021 | New notice | $35,012,500 | $25,300,000 | $9,712,500 | 7 | Apr 29, 2021 | sec.gov |
| Mar 26, 2021 | New notice | $2,000,000 | $2,000,000 | 3 | Mar 22, 2021 | sec.gov | |
| Feb 15, 2019 | New notice | $3,575,000 | $3,575,000 | 4 | Feb 6, 2019 | sec.gov | |
| Jan 9, 2017 | New notice | $862,857 | $862,857 | 2 | Dec 27, 2016 | sec.gov | |
| May 29, 2013 | New notice | $3,750,000 | $1,250,000 | $2,500,000 | 2 | May 21, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rachel Sha | Executive Officer, Director | |
| Kathryn Kousda | Executive Officer, Director | |
| Ann DeWitt | Director | |
| Livio Valenti | Executive Officer | |
| Peter Kolchinsky | Director | |
| Fenel Eloi | Director | |
| Linda Tussey | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Terrestrial Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.